SD Bioscience Signs Business Agreement with Heodak for Health Functional Food 사업

[Asia Economy Reporter Jang Hyowon] SD Bioscience (CEO Park Seolwoong) announced on the 14th that it has signed a strategic business agreement with Heodak, a leading chicken breast brand, to expand their mutual health functional food business.

(From left) Jang Deok-hyun, Vice President of Health Food Business Division at SD Bioscience, Kim In-sook, President of SD Bioscience, Park Seol-ung, Chairman of SD Bioscience, Kim Ju-hyung, Co-CEO of Heodak, Kwon Oh-jun, Vice President of Heodak. / Photo by SD Bioscience

The agreement ceremony held on the 10th at SD Bioscience’s headquarters located in Magok-dong, Gangseo-gu, Seoul, was attended by key officials from both companies, including Heodak co-CEO Kim Joohyung and SD Bioscience Chairman Park Seolwoong. They agreed to establish a comprehensive cooperation system based on the core competencies and infrastructure each company possesses, covering product planning, production, marketing, and distribution in the health functional food sector.

According to this business agreement, both companies plan to jointly plan and develop SD Bioscience’s health functional food brand within this year and introduce it through Heodak’s online distribution and sales channels.

They also stated that they will seek broad mutual cooperation measures, including jointly promoting domestic and international sales both online and offline, to create a foundation for mutual growth.

An SD Bioscience official said, "We are very pleased to collaborate with Heodak, the leading brand in chicken breast, in the health functional food business," adding, "We will continue to exchange ongoing mutual relations with Heodak and do our best to create healthy and transparent products that meet future consumer needs."

Meanwhile, SD Bioscience operates its flagship beauty brand SNP, as well as color cosmetics, men’s cosmetics, and sanitary pad brands, and has recently shown rapid growth in the health functional food business.

In particular, among the health functional foods currently operated, Manufacturing Plant 1 has a monthly production capacity of 2.83 million units, and combined with Manufacturing Plant 2, scheduled for completion in March next year, the production capacity is expected to expand to 120 million units.

After the completion of Plant 2, the range of health functional food products will expand to include soft capsules, hard capsules, and tablets. The company also plans to continue aggressive investment in health functional food facilities and R&D, including individually recognized raw materials being prepared by next year.

This content was produced with the assistance of AI translation services.